← Eichor
Condition: Prurigo Nodularis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Prurigo Nodularis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Determinants of Chronic Inflammatory Skin Disease Trajectories
Phase N/A · 1 location(s) · University Hospital Schleswig-Holstein · NCT05928169
China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project
Phase N/A · 1 location(s) · Peking University First Hospital · NCT05316805
Phase III Clinical Study of MG-K10 Humanized Mab Injection in Subjects With Prurigo Nodularis
Phase 3 · 1 location(s) · Shanghai Mabgeek Biotech.Co.Ltd · NCT06779136
Clinical Study of the Efficacy and Safety of SHR-1819 Injection in Adult Patients With Prurigo Nodularis
Phase 2/Phase 3 · 1 location(s) · Guangdong Hengrui Pharmaceutical Co., Ltd · NCT06554509
Early and Long-Term Efficacy and Immune Changes With Dupilumab in Prurigo Nodularis
Phase N/A · 1 location(s) · UMC Utrecht · NCT07276425
Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis
Phase 2 · 34 location(s) · Beijing InnoCare Pharma Tech Co., Ltd. · NCT07236099
Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in Adults
Phase N/A · 51 location(s) · Galderma R&D · NCT06988618
A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6 Months to <18 Years of Age With P
Phase 3 · 14 location(s) · Sanofi · NCT06293053
A Non-interventional Study to Describe the Dupilumab Long-term Treatment, Safety and Patient Reported Outcomes in Chroni
Phase N/A · 11 location(s) · Sanofi · NCT06087627
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.